0001950047-24-005024.txt : 20240625 0001950047-24-005024.hdr.sgml : 20240625 20240625163541 ACCESSION NUMBER: 0001950047-24-005024 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 241069393 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Arif Bilal CENTRAL INDEX KEY: 0001959750 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02129 144 1 primary_doc.xml 144 0001959750 XXXXXXXX LIVE 0000873303 SAREPTA THERAPEUTICS, INC. 001-14895 215 First Street Suite 415 Cambridge MA 02142 617-274-4000 BILAL ARIF Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

3898 638687.30 94523766 06/25/2024 NASDAQ Common 06/20/2024 Performance Stock Units Issuer N 3898 06/20/2024 N/A N 10b5-1 Sales for BILAL ARIF

215 First Street Suite 415 Cambridge MA 02142

COMMON 06/24/2024 7859 1281632.36 06/25/2024 03/11/2024 /s/ Bilal Arif